Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674119010 | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3674121017 | Benzocaine 10 mg and cetylpyridinium chloride 1.4 mg oromucosal lozenge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Benzocaine and cetylpyridinium only product in oromucosal dose form | true | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Compound anesthetic topical preparation (product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a pour principe actif (attribut) | Local anesthetic (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Product containing cetylpyridinium (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | benzocaïne | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a pour principe actif (attribut) | Benzocaine (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a pour principe actif (attribut) | cétylpyridinium | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a pour principe actif (attribut) | Cationic surfactant (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a pour principe actif (attribut) | Skin anti-infective (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a pour principe actif (attribut) | Local anti-infective (substance) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Product containing benzocaine and cetylpyridinium (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a une forme pharmaceutique (attribut) | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Product containing cetylpyridinium in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Product containing benzocaine in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a une forme pharmaceutique (attribut) | Lozenge | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | a une forme pharmaceutique (attribut) | Oromucosal lozenge | true | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | est un(e) (attribut) | Product manufactured as oromucosal dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Benzocaine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator value (attribute) | 1.4 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance (attribute) | Cetylpyridinium chloride (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Cetylpyridinium chloride (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance (attribute) | Benzocaine (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets